In the Mix: 20 More Articles — June 19, 2026
June 19, 2026. 20 articles reviewed below the CED clinical relevance threshold of 35. Listed in descending order of score.
DEA Selects Only Cannabis Opponents For Crucial June 29 Rescheduling Hearing
The DEA is holding a rescheduling hearing with panelists reportedly critical of cannabis, which may impact future research and clinical practice guidelines.
Read more →Can Marijuana Users Legally Own Guns Now? The Supreme Court Just Answered
The article details recent Supreme Court consideration of federal gun ownership restrictions for individuals using marijuana, a legal issue potentially relevant to patient disclosures.
Read more →‘New generation of moms’ say weed helps them ‘survive full-time parenting’ – Press Review
The Washington Post reports on research regarding cannabis and its perception as a less dangerous substance, potentially reflecting evolving public attitudes relevant to patient discussions.
Read more →Even Compliant Cannabis Packaging Can Appeal to Teens – Labroots
The article discusses how even compliant cannabis packaging may attract adolescent attention, which is relevant given potential impacts of cannabis on developing brains.
Read more →Bipartisan Lawmakers Seek To Extend Military Psychedelics Research Program Until 2033
The article reports on proposed legislation to extend military research into psychedelics, which may be relevant given increasing clinical interest in these substances.
Read more →Restaurateurs Call on Congress to Delay Intoxicating Hemp Cannabinoid Ban
The article details restaurateurs advocating for federal regulation of hemp-derived intoxicating cannabinoids instead of an outright ban, which may impact product availability and patient inquiries.
Read more →In the cannabis industry, ‘culture’ is revealed in hard times
This article discusses current events in the commercial cannabis sector, including market changes and company leadership, which may offer contextual awareness for clinicians observing patient product access and experiences.
Read more →NC lawmakers react to a retail cannabis marketplace announcement in Virginia – WRAL
The article reports Virginia’s planned launch of retail cannabis sales next July, which may be relevant to clinicians in neighboring states anticipating potential cross-border impacts.
Read more →Pacific Grove set to get first cannabis retailer after lottery selection – KSBW
This article reports on the selection of a cannabis retailer in Pacific Grove, California, which may indicate shifts in local cannabis market access.
Read more →Portable Cannabis Vaporizer Market Report Examines Leading – openPR.com
This report details market trends in portable cannabis vaporizers, potentially informing clinicians about evolving methods of cannabis administration among patients.
Read more →Two men face felony charges after police find THC vapes – Bryan College Station Eagle
This article reports on the arrest of two individuals for possession of marijuana and THC vapes following a traffic stop, potentially noting regional law enforcement activity regarding cannabis products.
Read more →Supreme Court Limits Federal Gun Ban on Drug Users – The Trace
The Supreme Court ruling clarifies federal firearm restrictions for individuals using any controlled substance, including marijuana, which may affect patient disclosures regarding legal state use.
Read more →Retail Cannabis Market Full Interview with Political Analyst Cayce Myers – WDBJ7
This news segment features an interview with a political analyst discussing the retail cannabis market, potentially offering context regarding evolving legal frameworks relevant to clinicians.
Read more →Eugene police warn of renewed gold bar scam targeting elderly residents – KMTR
This news report details a fraud scheme targeting seniors in Eugene, Oregon, which may be relevant as older adults are an increasing patient demographic for cannabis therapy.
Read more →Amazon ECS introduces new high-resolution metrics for faster service auto scaling – AWS
This article details improvements to Amazon ECS auto scaling, which may be relevant for clinicians using cloud computing infrastructure to manage large datasets or telehealth platforms.
Read more →European Coatings Show Conference is calling for papers
This article details a call for submissions to the European Coatings Show conference, potentially relevant as packaging materials impact product storage and delivery methods.
Read more →Mixed-Potential-Driven Deposition of Cu Films with Dilute Co Incorporation for Enhanced …
This research details copper film deposition techniques with cobalt incorporation, potentially relevant to analytical chemistry methods used in cannabinoid testing equipment development.
Read more →Suspected crack cocaine, marijuana and weapon recovered in Franklin traffic stop
This report details a traffic stop resulting in the seizure of marijuana alongside other controlled substances and a weapon, potentially reflecting co-occurring substance use patterns.
Read more →The hidden upside of adolescent impulsivity: Teens with attention issues take more risks to …
The article discusses a potential link between adolescent impulsivity, prosocial risk-taking, and increased cannabis use, which may be relevant given the age of initiation for some patients.
Read more →In a unanimous decision, the Supreme Court ruled that a longstanding federal ban on guns …
The article reports on a Supreme Court ruling regarding gun control, which may be relevant as polysubstance use is common among some patients utilizing cannabis.
Read more →Digest-Level Clinical Commentary
The digest suggests that cannabis medicine practice faces a critical inflection point where regulatory momentum toward rescheduling is being challenged by legitimate concerns about standardization, drug interactions, and youth access that the field has not adequately addressed. As clinicians, we must acknowledge that the current evidence base remains fragmented on dosing and safety across patient populations, and that advocacy for rescheduling without simultaneous commitment to rigorous pharmacological research and clinical guidelines risks undermining the legitimacy of cannabis as a therapeutic agent. The parallel discussions of gun rights, parenting use, and market expansion indicate that cannabis is rapidly becoming normalized in American culture while medical practice remains largely disconnected from the regulatory and safety conversations that should accompany this shift.
These items reflect the ongoing tension between cannabis’s evolving legal status and the lack of standardized clinical evidence to guide its use, particularly regarding safety in vulnerable populations like adolescents and pregnant individuals. The regulatory landscape remains fragmented, with federal rescheduling efforts proceeding despite concerns about product quality control and drug interactions, while state-level markets continue expanding ahead of comprehensive clinical guidance. Healthcare providers face practical challenges in counseling patients about cannabis use when federal restrictions limit research opportunities and evidence-based dosing protocols remain unavailable.
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
